Digital Pathology Market Size, Share, Growth Analysis, By Product(Software, device, and storage systems), By Application(Drug discovery & development, academic research, and disease diagnosis), By Type(Human pathology, Veterinary pathology), By End user(Pharmaceutical, Biotechnology), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35G2172 | Region: Global | Published Date: April, 2024
Pages: 219 |Tables: 115 |Figures: 77

Digital Pathology Market Insights

Digital Pathology Market size was valued at USD 1051.59 million in 2022 and is poised to grow from USD 1133.61 million in 2023 to USD 2067.36 million by 2031, at a CAGR of 7.8% during the forecast period (2024-2031). 

The global digital pathology market is a rapidly growing sector within the medical diagnostics and research industry, driven by the increasing demand for more accurate and efficient diagnostic tools. Digital pathology involves the digitization and analysis of pathology specimens, allowing for easier collaboration between pathologists, more precise diagnoses, and faster turnaround times. One of the key drivers of the digital pathology market is the growing demand for personalized medicine, which requires more precise and targeted diagnostics. Additionally, the increasing prevalence of cancer and other chronic diseases is driving the demand for more efficient diagnostic tools. The adoption of artificial intelligence and machine learning technologies in digital pathology is also expected to drive market growth, as these technologies can enhance diagnostic accuracy and efficiency.

However, the market is not without its challenges. The high cost of digital pathology systems and the need for skilled personnel to operate them may limit adoption, particularly in developing regions. Additionally, concerns over data privacy and security may also pose a challenge to market growth. Despite these challenges, the market presents significant opportunities for growth and innovation. The integration of digital pathology with other technologies, such as telemedicine and cloud computing, presents new avenues for collaboration and increased efficiency. The growing adoption of remote pathology consultations and digital pathology platforms in research and academic institutions also presents new opportunities for market growth.

Market Snapshot - 2024-2031

Global Market Size

USD 1051.59 million

Largest Segment

Device

Fastest Growth

Device

Growth Rate

7.8% CAGR

Global Digital Pathology Market 2021-2030 ($ Bn)
Country Share for North America Region- 2021 (%)

To get more reports on the above market click here to Buy The Report

Digital Pathology Market Segmental Analysis

Global Digital Pathology Market is segmented on the basis of product, application, and region. By product, the market is segmented into software, device, and storage systems. By application, the market is segmented into drug discovery & development, academic research, and disease diagnosis. By type, market is segmented into human pathology and veterinary pathology. By end use it is segmented into pharmaceutical and biotechnolog. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.  

Digital Pathology Market Analysis By Product

The device segment dominated the global market. This is primarily due to the increasing adoption of digital pathology in academic research activities, which require enhanced resolution. For example, F. Hoffmann-La Roche Ltd. received a CE marking for its VENTANA DP 600 slide scanner in June 2022, which is a next-generation high-capacity slide scanner that generates high-resolution digital images of stained tissue samples to aid in cancer diagnosis and treatment planning.

The software segment is expected to register the fastest growth rate over the forecast period. This growth is attributed to the increasing number of cancer cases and the focus of key market players on developing novel digital pathology systems in the industry. For instance, Xybion Corp. launched Pristima XD Digital Pathology in August 2021, which helps in improving lab throughput and streamlining workflows. F. Hoffmann-La Roche Ltd. also launched uPath enterprise software in January 2019, which is designed to improve performance, speed, and usability for digital pathology. Such innovative incorporation of integrated software helps in improving workflows.

Digital Pathology Market Analysis by Application

In 2022, the academic research segment dominated the digital pathology market. The dominance of this segment can be attributed to the increasing adoption of digital pathology in various research studies and the continual research in the development of cancer therapies. Several academic research institutes are collaborating with digital pathology providers to incorporate the technology into research activities. For instance, in November 2022, the University Medical Center Utrecht partnered with Paige to deploy the company's application in clinical use and conduct a clinical health economics study to support reimbursement and adoption of AI applications in pathology.

Tthe disease diagnosis segment is expected to witness the fastest growth rate, owing to the increasing prevalence of chronic diseases and the manufacturers' focus on developing rapid and novel diagnostics techniques to facilitate the circulation of inter- and intra-departmental information. The adoption of digital technologies helps in enhancing the efficiency of disease diagnosis and improving therapeutics. For example, in April 2022, PreciseDx collaborated with The Michael J. Fox Foundation to launch AI-enabled digital pathology technology for the diagnosis of Parkinson's disease before severe symptoms are seen in patients.

Digital Pathology Market Analysis by type 

Human Pathology: This segment can be considered as the foundation of the digital pathology market. Basically, it is a micro-analysis that might involve diagnosis of diseases through analyzing samples of human tissues. Digital tools allow pathologists to dicuss high-resolution digital slides on their PC and laptops which makes it very convenient. This means that there is quicker diagnosis that enables the physicians to come up with the suitable treatment plans appropriately. Further, digital pathology helps reduce diagnostic errors especially for ambiguous cases as once observed by a pathologist digital pathology may help to enhance patients’ outcomes especially for cancer. 
 
Veterinary Pathology: Sure, digital pathology is not a novelty for people anymore. It is also progressively assuming a crucial significance in the sphere of veterinary medicine as well. This segment is more dedicated to examining the client’s pets or livestock to identify the diseases that have affected them. It was also noted that through digital mediums, veterinary pathologists are able to consult and share intricate cases among practices. These discussions make it easier to diagnose animal illnesses and treat them in the best way thus improving their quality of life. 

Digital Pathology Market Analysis by end user 

Pharmaceutical and Biotechnology Companies: When most people think of digital pathology, they immediately relate it to diagnosis of patients; however, it also has a great role to play in drug discovery and development. The above segment is focused on delivering services to pharmaceutical and biotech clients that are looking for creating new drugs. Computational resources enable scientists to examine tissues on the cellular level as well as evaluate the efficiency of the future medications and spot possible adverse reactions. This de-risked strategy beneficially accelerates the drug discovery process and consequently it delivers new treatments to the patients earlier. 
 
Hospitals and Reference Laboratories: Apart from being used in research, digital pathology has been adopted in hospitals and reference laboratories with a view of improving the patient’s outcome. This segment needs to address the application of digital pathology in, among other things, routine diagnosis. It then becomes easy for the pathologists to share high resolution slides through display technologies making it easy to consult counterparts and obtain a second opinion. Following a team approach can enhance the speed of making diagnosis and the quality of the diagnosis hence improving the lot of the patients. 

Global Digital Pathology Market Size By Product 2021(%)

To get detailed analysis on other segments, Request For Free Sample Report

Digital Pathology Market Regional Insights

In 2022, North America dominated the global digital pathology market. This can be attributed to various factors, including increasing government initiatives towards the development of technologically advanced pathologies, continual investments in research and development, rising adoption of digital imaging, and the presence of key market players in the region. For instance, PathAI launched AISight, a digital pathology platform in 13 leading health systems across the U.S. to participate in an Early Access Program. The increasing usage of digital pathology in academic research and disease diagnosis is also contributing to the growth of the regional market.

Asia Pacific is expected to be the fastest-growing region in the digital pathology market, with a rising focus on investments in the medical field, rapid digitalization, and increasing digital imaging penetration in developing economies. The region is also witnessing a rising prevalence of cancer, which is driving the need for novel treatment options, thereby further propelling market growth. Qritive has recently entered into a collaboration with Corista for the integration of AI using the company's DP3, a DICOM-compliant pathology software in digital pathology. These initiatives help in providing better patient care, novel treatment options, and subsequently reducing laboratory cost expenses.

Global Digital Pathology Market Size By Geography, 2021-2030
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Digital Pathology Market Dynamics

Digital Pathology Market Drivers

Advancements in Technology

  • Continuous advancements in digital imaging technology, such as whole-slide imaging (WSI), high-resolution scanners, and image analysis software, are driving the adoption of digital pathology. These technological innovations offer improved image quality, faster scanning times, and enhanced analysis capabilities, leading to more accurate and efficient diagnoses. For example, the development of deep learning algorithms and artificial intelligence (AI) tools has enabled automated image analysis and detection of abnormalities in pathology slides, aiding pathologists in their decision-making process.

Need for Efficient Workflow and Collaboration

  • Digital pathology enables streamlined workflows and enhances collaboration among healthcare professionals. With digital slides, pathologists can access and review cases remotely, reducing the need for physical slide transportation and allowing for faster consultation and diagnosis. This is particularly beneficial in areas with limited access to specialized pathology expertise. Moreover, digital pathology facilitates the seamless sharing of images for second opinions, research collaboration, and educational purposes, fostering improved patient care and knowledge sharing among pathologists.

Digital Pathology Market Restraints

Cost and Infrastructure Requirements

  • Implementation of digital pathology systems requires significant upfront investment in scanners, storage infrastructure, and software solutions. The cost of digitizing slides, maintaining digital archives, and training personnel can be substantial, particularly for small laboratories or healthcare facilities with limited budgets. Additionally, the integration of digital pathology into existing laboratory workflows and the need for IT support and infrastructure upgrades can pose challenges for some organizations.

Regulatory and Standardization Challenges

  • The adoption of digital pathology is subject to regulatory requirements and standards that vary across different regions. The validation and regulatory approval of digital pathology systems and software can be a complex and time-consuming process. Moreover, ensuring data privacy, security, and compliance with patient confidentiality regulations while transmitting and storing digital pathology images presents challenges that need to be addressed.

Request Free Customization of this report to help us to meet your business objectives.

Digital Pathology Market Competitive Landscape

The Global Digital Pathology Market is highly competitive, with a large number of players operating in the space. Some of the key players in the market are focused on product development and innovation, strategic partnerships and collaborations, and mergers and acquisitions to strengthen their market position. They are also investing heavily in research and development activities to develop advanced digital pathology solutions that offer improved accuracy, speed, and efficiency. In addition, companies are expanding their geographic reach by targeting emerging markets in Asia-Pacific and Latin America, which offer significant growth opportunities due to increasing healthcare expenditure and the rising prevalence of chronic diseases. Overall, the competitive landscape of the digital pathology market is expected to remain intense, with companies vying for a larger share of the rapidly growing market.

Digital Pathology Market Top Player’s Company Profiles

  • Leica Biosystems (Germany)
  • Hamamatsu Photonics (Japan)
  • 3DHISTECH (Hungary)
  • Ventana Medical Systems (US)
  • Apollo Enterprise Imaging (US)
  • Olympus Corporation (Japan)
  • Mikroscan Technologies (US)
  • Inspirata (US)
  • PerkinElmer (US)
  • Huron Digital Pathology (Canada)
  • Sectra AB (Sweden)
  • PathAI (US)
  • Indica Labs (US)
  • F. Hoffmann-La Roche (Switzerland)
  • Nikon Corporation (Japan)
  • Danaher Corporation (US)
  • Visiopharm (Denmark)

Digital Pathology Market Recent Developments

  • F. Hoffmann-La Roche Ltd. and PathAl established a collaboration in February 2024 to create digital pathology algorithms using artificial intelligence (Al) for Roche's Tissue Diagnostics division. 
  • The availability of an integrated AI-powered platform and digital pathology solutions, which combine image analysis, DICOM, digital pathology, and AI into a single, comprehensive offering, was announced by Pramana and Gestalt in October 2023. 
  • Paige and Ohio State Wexner Medical Center partnered in August 2023 to investigate AI solutions that use Paige Prostate Detect, the only FDA-approved AI tool in pathology for prostate cancer detection.

Digital Pathology Key Market Trends

  • Telepathology and Remote Consultation: The increasing adoption of telepathology allows for remote diagnosis and consultation, enabling pathologists to collaborate and provide expert opinions regardless of geographical constraints. Telepathology has gained prominence during the COVID-19 pandemic, as it facilitates remote working and minimizes the risk of exposure for pathologists. For example, pathologists can remotely review and discuss cases with colleagues, participate in multidisciplinary tumor boards, or provide consultations to underserved areas or regions facing a shortage of pathology expertise.
  • Integration of Artificial Intelligence and Machine Learning: The integration of AI and machine learning algorithms into digital pathology platforms is a significant trend. AI can assist pathologists in tasks such as automated tissue recognition, detection of anomalies, quantification of biomarkers, and prediction of disease outcomes. These technologies have the potential to improve efficiency, accuracy, and reproducibility in pathology diagnosis. For instance, AI algorithms can help in the automated detection and classification of cancer cells or the identification of specific features in histopathological images.

Digital Pathology Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global digital pathology market analysis, the market growth is driven by increasing adoption of digital pathology solutions in diagnostic laboratories and research institutions, the need for efficient and accurate diagnosis in healthcare, and the advancements in technology such as whole-slide imaging and cloud-based platforms. Additionally, the rising prevalence of chronic diseases and the growing demand for personalized medicine are further fueling market expansion. The market is characterized by intense competition among key players, with companies focusing on strategic partnerships, product launches, and technological advancements to gain a competitive edge. North America is anticipated to hold a substantial market share due to the presence of advanced healthcare infrastructure and the early adoption of digital pathology technologies. However, the Asia-Pacific region is expected to witness the highest growth rate, attributed to the increasing healthcare expenditure, improving healthcare infrastructure, and rising awareness about the benefits of digital pathology in emerging economies. Overall, the digital pathology market is poised for significant growth as it offers numerous advantages over traditional pathology methods, such as improved efficiency, remote access to cases, and enhanced collaboration among healthcare professionals.

Report Metric Details
Market size value in 2022 USD 1051.59 million
Market size value in 2031 USD 2067.36 million
Growth Rate 7.8%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Product
    • Software, device, and storage systems
  • Application
    • Drug discovery & development, academic research, and disease diagnosis
  • Type
    • Human pathology, Veterinary pathology
  • End user
    • Pharmaceutical, Biotechnology
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Leica Biosystems (Germany)
  • Hamamatsu Photonics (Japan)
  • 3DHISTECH (Hungary)
  • Ventana Medical Systems (US)
  • Apollo Enterprise Imaging (US)
  • Olympus Corporation (Japan)
  • Mikroscan Technologies (US)
  • Inspirata (US)
  • PerkinElmer (US)
  • Huron Digital Pathology (Canada)
  • Sectra AB (Sweden)
  • PathAI (US)
  • Indica Labs (US)
  • F. Hoffmann-La Roche (Switzerland)
  • Nikon Corporation (Japan)
  • Danaher Corporation (US)
  • Visiopharm (Denmark)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Digital Pathology Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Digital Pathology Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Digital Pathology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Digital Pathology Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Digital Pathology Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Digital Pathology Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Digital Pathology Market size was valued at USD 1051.59 million in 2022 and is poised to grow from USD 1133.61 million in 2023 to USD 2067.36 million by 2031, at a CAGR of 7.8% during the forecast period (2024-2031). 

The Global Digital Pathology Market is highly competitive, with a large number of players operating in the space. Some of the key players in the market are focused on product development and innovation, strategic partnerships and collaborations, and mergers and acquisitions to strengthen their market position. They are also investing heavily in research and development activities to develop advanced digital pathology solutions that offer improved accuracy, speed, and efficiency. In addition, companies are expanding their geographic reach by targeting emerging markets in Asia-Pacific and Latin America, which offer significant growth opportunities due to increasing healthcare expenditure and the rising prevalence of chronic diseases. Overall, the competitive landscape of the digital pathology market is expected to remain intense, with companies vying for a larger share of the rapidly growing market. 'Philips Healthcare (Netherlands)', 'Leica Biosystems (Germany)', 'Roche Diagnostics (Switzerland)', 'Hamamatsu Photonics (Japan)', '3DHISTECH (Hungary)', 'Ventana Medical Systems (US)', 'GE Healthcare (US)', 'Apollo Enterprise Imaging (US)', 'Olympus Corporation (Japan)', 'Mikroscan Technologies (US)', 'Inspirata (US)', 'PerkinElmer (US)', 'Huron Digital Pathology (Canada)', 'Sectra AB (Sweden)', 'PathAI (US)', 'Indica Labs (US)', 'F. Hoffmann-La Roche (Switzerland)', 'Nikon Corporation (Japan)', 'Danaher Corporation (US)', 'Visiopharm (Denmark)'

Continuous advancements in digital imaging technology, such as whole-slide imaging (WSI), high-resolution scanners, and image analysis software, are driving the adoption of digital pathology. These technological innovations offer improved image quality, faster scanning times, and enhanced analysis capabilities, leading to more accurate and efficient diagnoses. For example, the development of deep learning algorithms and artificial intelligence (AI) tools has enabled automated image analysis and detection of abnormalities in pathology slides, aiding pathologists in their decision-making process.

Telepathology and Remote Consultation: The increasing adoption of telepathology allows for remote diagnosis and consultation, enabling pathologists to collaborate and provide expert opinions regardless of geographical constraints. Telepathology has gained prominence during the COVID-19 pandemic, as it facilitates remote working and minimizes the risk of exposure for pathologists. For example, pathologists can remotely review and discuss cases with colleagues, participate in multidisciplinary tumor boards, or provide consultations to underserved areas or regions facing a shortage of pathology expertise.

In 2022, North America dominated the global digital pathology market. This can be attributed to various factors, including increasing government initiatives towards the development of technologically advanced pathologies, continual investments in research and development, rising adoption of digital imaging, and the presence of key market players in the region. For instance, PathAI launched AISight, a digital pathology platform in 13 leading health systems across the U.S. to participate in an Early Access Program. The increasing usage of digital pathology in academic research and disease diagnosis is also contributing to the growth of the regional market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35G2172

$5,300
BUY NOW GET FREE SAMPLE